Home News

First half 2021 results presentation

Operating income, growth figures, profitability and how our products have behaved.

Wed, 28/07/2021 - 00:00 0 min
Download related document
No votes yet
 
Related
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specializing and engaging in the research,...
2 min
29/04/2021
ROVI participates in the manufacture of the active substance of Moderna’s COVID...
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specializing and engaging in the research,...
2 min
12/04/2021
ROVI achieves a 10% increase in operating income and 55% in net profit
ROVI achieves a 10% increase in operating income and 55% in net profit
Laboratorios Farmacéuticos Rovi, SA (BME: ROVI), company Pan-European pharmaceutical company specialized and dedicated to the research,...
5 min
24/02/2021